
What You Ought to Know:
– Oxford Cancer Biomarkers Ltd (OCB), a pacesetter in molecular precision most cancers diagnostic assessments, has at the moment introduced a brand new partnership with Mira Precision Health Inc.
– This collaboration goals to advance OCB’s proprietary ToxNav® test in the USA, a revolutionary precision oncology instrument designed to determine sufferers at excessive threat of extreme toxicity from widespread chemotherapy remedies.
– Mira Precision Well being, headquartered on the Mason 5155 BioHub in Mason, Ohio, is devoted to advancing precision medication by delivering progressive options that empower clinics, well being methods, and unbiased suppliers. Collectively, OCB and Mira Precision Well being will work to ascertain a considerable future market and gross sales presence for ToxNav® within the U.S..
Revolutionizing Most cancers Drug Security with ToxNav®
The ToxNav® take a look at identifies most cancers sufferers who’ve a excessive chance of experiencing excessive toxicity when handled with 5FU/capecitabine, a number of the most generally used most cancers medication globally. In extreme instances, this toxicity will be deadly.
The ToxNav® take a look at enhances scientific decision-making via complete genetic profiling and straight aligns with current updates to the Nationwide Complete Most cancers Community (NCCN) Tips, which suggest DPYD testing for colorectal most cancers sufferers receiving fluoropyrimidine-based remedies.
Dr. David Kerr, Founder and Director of the Board of OCB, and Professor of Most cancers Medication at Oxford College, commented, “We developed our ToxNav take a look at to determine most cancers sufferers which have a excessive chance of present process excessive toxicity to 5FU/capecitabine therapy, which is without doubt one of the most generally used most cancers medication on the planet. Now we have already clinically confirmed that ToxNav identifies sufferers which are vulnerable to excessive toxicity and are excited to have partnered the take a look at with Mira Precision, who’ve complementary experience to advance ToxNav within the USA. We look ahead to a protracted and productive relationship with Mira Precision as we advance ToxNav to widen its scientific utility within the USA and save extra affected person lives”.